Cargando…
P787: ALTERNATIVE PATHWAY MASP-3 INHIBITOR OMS906: RESULTS FROM A FIRST-IN-MAN PHASE 1 STUDY IN HEALTHY SUBJECTS AND STUDY DESIGN OF TWO ONGOING CLINICAL TRIALS IN PATIENTS WITH PNH
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430637/ http://dx.doi.org/10.1097/01.HS9.0000970052.45858.28 |
_version_ | 1785091014168412160 |
---|---|
author | Griffin, Morag Humphreys, Jane Philpot, Edward Jason Cummings, W. Pullman, William |
author_facet | Griffin, Morag Humphreys, Jane Philpot, Edward Jason Cummings, W. Pullman, William |
author_sort | Griffin, Morag |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10430637 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-104306372023-08-17 P787: ALTERNATIVE PATHWAY MASP-3 INHIBITOR OMS906: RESULTS FROM A FIRST-IN-MAN PHASE 1 STUDY IN HEALTHY SUBJECTS AND STUDY DESIGN OF TWO ONGOING CLINICAL TRIALS IN PATIENTS WITH PNH Griffin, Morag Humphreys, Jane Philpot, Edward Jason Cummings, W. Pullman, William Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430637/ http://dx.doi.org/10.1097/01.HS9.0000970052.45858.28 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Posters Griffin, Morag Humphreys, Jane Philpot, Edward Jason Cummings, W. Pullman, William P787: ALTERNATIVE PATHWAY MASP-3 INHIBITOR OMS906: RESULTS FROM A FIRST-IN-MAN PHASE 1 STUDY IN HEALTHY SUBJECTS AND STUDY DESIGN OF TWO ONGOING CLINICAL TRIALS IN PATIENTS WITH PNH |
title | P787: ALTERNATIVE PATHWAY MASP-3 INHIBITOR OMS906: RESULTS FROM A FIRST-IN-MAN PHASE 1 STUDY IN HEALTHY SUBJECTS AND STUDY DESIGN OF TWO ONGOING CLINICAL TRIALS IN PATIENTS WITH PNH |
title_full | P787: ALTERNATIVE PATHWAY MASP-3 INHIBITOR OMS906: RESULTS FROM A FIRST-IN-MAN PHASE 1 STUDY IN HEALTHY SUBJECTS AND STUDY DESIGN OF TWO ONGOING CLINICAL TRIALS IN PATIENTS WITH PNH |
title_fullStr | P787: ALTERNATIVE PATHWAY MASP-3 INHIBITOR OMS906: RESULTS FROM A FIRST-IN-MAN PHASE 1 STUDY IN HEALTHY SUBJECTS AND STUDY DESIGN OF TWO ONGOING CLINICAL TRIALS IN PATIENTS WITH PNH |
title_full_unstemmed | P787: ALTERNATIVE PATHWAY MASP-3 INHIBITOR OMS906: RESULTS FROM A FIRST-IN-MAN PHASE 1 STUDY IN HEALTHY SUBJECTS AND STUDY DESIGN OF TWO ONGOING CLINICAL TRIALS IN PATIENTS WITH PNH |
title_short | P787: ALTERNATIVE PATHWAY MASP-3 INHIBITOR OMS906: RESULTS FROM A FIRST-IN-MAN PHASE 1 STUDY IN HEALTHY SUBJECTS AND STUDY DESIGN OF TWO ONGOING CLINICAL TRIALS IN PATIENTS WITH PNH |
title_sort | p787: alternative pathway masp-3 inhibitor oms906: results from a first-in-man phase 1 study in healthy subjects and study design of two ongoing clinical trials in patients with pnh |
topic | Posters |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430637/ http://dx.doi.org/10.1097/01.HS9.0000970052.45858.28 |
work_keys_str_mv | AT griffinmorag p787alternativepathwaymasp3inhibitoroms906resultsfromafirstinmanphase1studyinhealthysubjectsandstudydesignoftwoongoingclinicaltrialsinpatientswithpnh AT humphreysjane p787alternativepathwaymasp3inhibitoroms906resultsfromafirstinmanphase1studyinhealthysubjectsandstudydesignoftwoongoingclinicaltrialsinpatientswithpnh AT philpotedward p787alternativepathwaymasp3inhibitoroms906resultsfromafirstinmanphase1studyinhealthysubjectsandstudydesignoftwoongoingclinicaltrialsinpatientswithpnh AT jasoncummingsw p787alternativepathwaymasp3inhibitoroms906resultsfromafirstinmanphase1studyinhealthysubjectsandstudydesignoftwoongoingclinicaltrialsinpatientswithpnh AT pullmanwilliam p787alternativepathwaymasp3inhibitoroms906resultsfromafirstinmanphase1studyinhealthysubjectsandstudydesignoftwoongoingclinicaltrialsinpatientswithpnh |